Hans van den Heuvel

5 Table 4. Pregnancy outcomes SAFE@HOME n = 103 Control n = 133 p- value Final maternal diagnosis of HDP in current pregnancy n (%) Gestational hypertension 9 (8.7) 4 (3.0) 0.06 Preeclampsia 22 (21.4) 27 (20.3) 0.84 HELLP syndrome 1 (1.0) 0 (0) 0.44 Chronic hypertension without PE 23 (22.3) 26 (19.5) 0.60 No HDP (normotensive) 48 (46.6) 76 (57.1) 0.11 Suspected fetal growth restriction n (%) 12 (11.7) 13 (9.8) 0.64 Glucocorticoid administration n (%) 15 (14.6) 10 (7.5) 0.08 MgSO4 administration n (%) 9 (8.7) 12 (9.0) 0.94 Use of anti-hypertensive drugs <20 w GA n (%) 39 (37.9) 41 (30.8) 0.26 Use of anti-hypertensive drugs >20 w GA n (%) 56 (54.4) 58 (43.6) 0.10 iv antihypertensive drugs ante-partum n (%) 4 (3.9) 9 (6.8) 0.34 Iv antihypertensive drugs post-partum n (%) 6 (5.8) 4 (3.0) 0.29 Mode of delivery Induction of labour n (%) 58 (56.3) 51 (38.3) 0.006 *because of hypertension n (%) 33 (56.9) 28 (54.9) 0.99 Primary caesarean section n (%) 24 (23.3) 34 (25.6) 0.69 *because of hypertension n (%) 7 (29.2) 12 (35.3) 0.62 Vaginal delivery n (%) 61 (59.2) 72 (54.1) 0.43 Instrumental delivery n (%) 9 (8.7) 6 (4.5%) 0.19 Secondary caesarean section n (%) 9 (8.7) 21 (15.8) 0.11 Fetal/neonatal outcome GA at delivery (weeks) mean (SD) 38.3 (2.1) 38.8 (2.3) 0.11 Birth weight (gram) mean (SD) 3081 (638) 3203 (694) 0.17 Birth weight <5th percentile n (%) 5 (4.9) 12 (9.0) 0.22 APGAR <7 at 5 minutes n (%) 3 (2.9) 7 (5.3) 0.52 NICU admission n (%) 2 (1.9) 6 (4.5) 0.47 Legend: GA, gestational age; HDP, hypertensive disorder of pregnancy; PE, preeclampsia SAFE@HOME TELEMONITORING FOR WOMEN AT RISK OF PREECLAMPSIA 77